Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Chem Biol Drug Des. 2010 May 11;76(2):164–173. doi: 10.1111/j.1747-0285.2010.00988.x

Figure 2. Anti-cancer activity of B3CD in a NB animal model.

Figure 2

SMS-KCNR cells were inoculated subcutaneously in one flank of immunodeficient nude mice. After tumor development, mice were treated intraperitoneally every other day with either B3CD (150 μg/Kg) or vehicle control. Mice were weighed (right panels) and tumor size calculated (left panel) using a caliper every 2 days.